Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.

Article  PubMed  Google Scholar 

Zhang M, Ding C, Xu L, Ou B, Feng S, Wang G, et al. Comparison of a tumor-ratio-metastasis staging system and the 8th AJCC TNM staging system for gastric cancer. Front Oncol. 2021;11: 595421.

Article  PubMed  PubMed Central  Google Scholar 

Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand. 1965;64:31–49.

Article  CAS  PubMed  Google Scholar 

Leocata P, Ventura L, Giunta M, Guadagni S, Fortunato C, Discepoli S, et al. Gastric carcinoma: a histopathological study of 705 cases. Ann Ital Chir. 1998;69:331–7.

CAS  PubMed  Google Scholar 

Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: diagnostic relevance and prognostic value. World J Gastroenterol. 2014;20:5679–84.

Article  PubMed  PubMed Central  Google Scholar 

Oue N, Sentani K, Sakamoto N, Uraoka N, Yasui W. Molecular carcinogenesis of gastric cancer: Lauren classification, mucin phenotype expression, and cancer stem cells. Int J Clin Oncol. 2019;24:771–8.

Article  CAS  PubMed  Google Scholar 

Díaz Del Arco C, Ortega Medina L, Estrada Muñoz L, Gómez G, de Las HS, Fernández Aceñero MJ. Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis. Histol Histopathol. 2021;36:587–613.

PubMed  Google Scholar 

Singh S, Bhat MY, Sathe G, Gopal C, Sharma J, Madugundu AK, et al. Proteomic signatures of diffuse and intestinal subtypes of gastric cancer. Cancers. 2021;13:5930.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chia N-Y, Tan P. Molecular classification of gastric cancer. Ann Oncol Off J Eur Soc Med Oncol. 2016;27:763–9.

Article  Google Scholar 

Wang Q, Liu G, Hu C. Molecular classification of gastric adenocarcinoma. Gastroenterol Res. 2019;12:275–82.

Article  CAS  Google Scholar 

Serra O, Galán M, Ginesta MM, Calvo M, Sala N, Salazar R. Comparison and applicability of molecular classifications for gastric cancer. Cancer Treat Rev. 2019;77:29–34.

Article  CAS  PubMed  Google Scholar 

Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3:251–61.

PubMed  PubMed Central  Google Scholar 

Ikoma N, Agnes A, Chen H-C, Wang X, Blum MM, Das P, et al. Linitis plastica: a distinct type of gastric cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2020;24:1018–25.

Article  Google Scholar 

Okamoto T, Suzuki H, Fukuda K. Gastric linitis plastica due to signet-ring cell carcinoma with Krukenberg tumors diagnosed by endoscopic ultrasound-guided fine-needle aspiration. Clin J Gastroenterol. 2021;14:994–1003.

Article  PubMed  Google Scholar 

Shiratori Y, Ikeya T, Suzuki K, Nakamura K, Fukuda K. The rare case of elevated signet ring cell gastric carcinoma with helicobacter pylori-naïve mucosa. Clin J Gastroenterol. 2020;13:736–9.

Article  PubMed  Google Scholar 

Yashiro M, Hirakawa K. Cancer-stromal interactions in scirrhous gastric carcinoma. Cancer Microenviron. 2010;3:127–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24:1–21.

Article  Google Scholar 

Iwasaki Y, Terashima M, Mizusawa J, Katayama H, Nakamura K, Katai H, et al. Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial. Gastric Cancer. 2021;24:492–502. https://doi.org/10.1007/s10120-020-01136-7.

Article  CAS  PubMed  Google Scholar 

Hartgrink HH. Improving outcome for scirrhous gastric cancer. Gastric Cancer. 2009;12:3–5.

Article  CAS  PubMed  Google Scholar 

Chang JM, Lara KA, Gray RJ, Pockaj BA, Wasif N. Clinical outcomes after surgery for linitis plastica of the stomach: analysis of a population cancer registry. Am Surg. 2017;83:23–9.

Article  PubMed  Google Scholar 

Pedrazzani C, Marrelli D, Pacelli F, Di Cosmo M, Mura G, Bettarini F, et al. Gastric linitis plastica: which role for surgical resection? Gastric Cancer. 2012;15:56–60.

Article  PubMed  Google Scholar 

Miki Y, Yashiro M, Moyano-Galceran L, Sugimoto A, Ohira M, Lehti K. Crosstalk between cancer associated fibroblasts and cancer cells in scirrhous type gastric cancer. Front Oncol. 2020;10:568557.

Article  PubMed  PubMed Central  Google Scholar 

Katona BW, Rustgi AK. Gastric cancer genomics: advances and future directions. Cell Mol Gastroenterol Hepatol. 2017;3:211–7.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Schaefer A, Wang Y, Hodge RG, Blake DR, Papageorge JN, et al. Gain-of-function RHOA mutations promote focal adhesion kinase activation and dependency in diffuse gastric cancer. Cancer Discov. 2020;10:288–305.

Article  CAS  PubMed  Google Scholar 

Cho S-J, Yoon C, Lee JH, Chang KK, Lin J-X, Kim Y-H, et al. KMT2C mutations in diffuse-type gastric adenocarcinoma promote epithelial-to-mesenchymal transition. Clin Cancer Res. 2018;24:6556–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ichikawa H, Nagahashi M, Shimada Y, Hanyu T, Ishikawa T, Kameyama H, et al. Actionable gene-based classification toward precision medicine in gastric cancer. Genome Med. 2017;9:93.

Article  PubMed  PubMed Central  Google Scholar 

Vivier-Chicoteau J, Lambert J, Coriat R, Bonnot PE, Goere D, Roche B, et al. Development and internal validation of a diagnostic score for gastric linitis plastica. Gastric Cancer. 2020;23:639–47.

Article  CAS  PubMed  Google Scholar 

Sohn BH, Hwang J-E, Jang H-J, Lee H-S, Oh SC, Shim J-J, et al. Clinical significance of four molecular subtypes of gastric cancer identified by the cancer genome atlas project. Clin Cancer Res. 2017;23:4441–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Foroutan M, Bhuva DD, Lyu R, Horan K, Cursons J, Davis MJ. Single sample scoring of molecular phenotypes. BMC Bioinformatics. 2018;19:404.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niu B, Ye K, Zhang Q, Lu C, Xie M, McLellan MD, et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinforma Oxf Engl. 2014;30:1015–6.

Article  CAS  Google Scholar 

Talevich E, Shain AH, Botton T, Bastian BC. CNVkit: genome-wide copy number detection and visualization from targeted DNA sequencing. PLoS Comput Biol. 2016;12: e1004873.

Article  PubMed  PubMed Central  Google Scholar 

Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12:R41.

Article  PubMed  PubMed Central  Google Scholar 

Mayakonda A, Lin D-C, Assenov Y, Plass C, Koeffler HP. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28:1747–56.

Article  CAS  PubMed  PubMed Central  Google Scholar 

McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. Omics J Integr Biol. 2012;16:284–7.

Article  CAS  Google Scholar 

Lei L, Hong L-L, Ling Z-N, Zhong Y, Hu X-Y, Li P, et al. A Potential oncogenic role for PFKFB3 overexpression in gastric cancer progression. Clin Transl Gastroenterol. 2021;12: e00377.

Article  PubMed  PubMed Central  Google Scholar 

Chen X-L, Hong L-L, Wang K-L, Liu X, Wang J-L, Lei L, et al. Deregulation of CSMD1 targeted by microRNA-10b drives gastric cancer progression through the NF-κB pathway. Int J Biol Sci. 2019;15:2075–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Yuen ST, Xu J, Lee SP, Yan HHN, Shi ST, et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat Genet. 2014;46:573–82.